Low Dose Immunotherapy

 
IMG_4249.jpeg
 
 

LDI

A healthy, balanced immune system that functions optimally and is able to recognize pathogens versus our own healthy tissues is imperative for protection against diseases. When our immune system is not able to properly fight off the pathogen or unable to recognize the pathogen versus our own tissues it is important to bring in immune modulation or regulation techniques that will bring the immune system back into balance. Many external and internal influences create a loss of an appropriate immune “tolerance” and cause tissue inflammation, possible damage, and many disease processes including chronic conditions such as autoimmune diseases, chronic fatigue, pain conditions, and many other inflammatory disorders.  There are new approaches to immune desensitization called Low Dose Allergy Desensitization (LDA) and Low Dose Immunotherapy (LDI) that restore tolerance to external and internal influences, thus halting the disease process. 

The history of these new treatments began in 1959 in London where Dr. Popper, an EENT physician discovered that hyaluronidase injected into the nasal mucosa of his patients with nasal polyps helped to relieve their allergy symptoms. In 1967, Dr. McEwen of London took this further by showing that glucuronidase (derived from hyaluronidase) had desensitizing activity and when mixed with a miniscule dose of an allergen or antigen it could stop allergic reactions by restoring tolerance to the T cells of the immune system.  Dr Ewen’s work was called Enzyme Potentiated Desensitization (EPD). LDA was patterned after EPD in the United States and further developed by Dr. Shrader. LDI was developed by Dr. Vincent in Alaska and emphasizes using LDA for more than typical allergies, such as desensitizing the immune response to certain bacteria, viruses, parasites, and more.

LDI can treat all types of diseases including, but not limited to Lyme disease, multiple sclerosis, Crohn’s disease, autism, myositis, fibromyalgia, chronic fatigue, autoimmune arthritis, ulcerative colitis, endometriosis, sarcoidosis, autoimmune hepatitis, psoriasis, and many more. The antigens used in the procedure are sterilized and can include dead bacteria, fungi, foods, chemicals, plants, samples of tissue or bodily substance from you, or many other items. The antigens are diluted (often to a trillion to one or further) and the dose used is miniscule and administered in an injection or sublingually (under your tongue) along with the needed enzyme. Once the right trigger is found and immune tolerance is restored, then the disease process can be stopped and symptoms will diminish. 

 
 
Alison Kerns